Literature DB >> 11384008

Vision multiplexing: an engineering approach to vision rehabilitation device development.

E Peli1.   

Abstract

Multiplexing is the transmission of two or more messages simultaneously over the same communication channel in a way that enables them to be separated and used at the receiving end. The normal visual system provides us with a very wide field of view at an apparent high resolution. The wide field of view is continuously monitored at a low resolution, providing information for navigation and detection of objects of interest. These objects of interest are sampled over time using the high-resolution fovea. Most disabling visual conditions impact only one of the components, the peripheral low-resolution wide field or the central high-resolution fovea. The loss of one of these components prevents the interplay of central and peripheral vision needed for normal function and causes disability. Traditionally low-vision aids replace or supplement the missing function, but usually at a cost of a significant loss in the surviving function. For example, magnifying devices increase resolution but reduce the field of view, whereas minifying devices increase the field of view but reduce resolution. A proposal to resolve many of the problems of current visual aids by exploring a general engineering approach--vision multiplexing--that takes advantage of the dynamic nature of human vision is presented. Vision multiplexing seeks to provide both the wide field of view and the high-resolution information in ways that could be accessed and interpreted by the visual system. This paper describes the use of optical methods and computer technologies in the development of a number of new visual aids, all of which apply vision multiplexing to restore the interplay of central and peripheral vision using eye movements in a natural way.

Entities:  

Mesh:

Year:  2001        PMID: 11384008     DOI: 10.1097/00006324-200105000-00014

Source DB:  PubMed          Journal:  Optom Vis Sci        ISSN: 1040-5488            Impact factor:   1.973


  34 in total

Review 1.  High Tech Aids Low Vision: A Review of Image Processing for the Visually Impaired.

Authors:  Howard Moshtael; Tariq Aslam; Ian Underwood; Baljean Dhillon
Journal:  Transl Vis Sci Technol       Date:  2015-08-14       Impact factor: 3.283

2.  Establishing Mobility Measures to Assess the Effectiveness of Night Vision Devices: Results of a Pilot Study.

Authors:  Kim T Zebehazy; George J Zimmerman; Alex R Bowers; Gang Luo; Eli Peli
Journal:  J Vis Impair Blind       Date:  2005-10

3.  Use of an augmented-vision device for visual search by patients with tunnel vision.

Authors:  Gang Luo; Eli Peli
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-09       Impact factor: 4.799

4.  Where people look when watching movies: do all viewers look at the same place?

Authors:  Robert B Goldstein; Russell L Woods; Eli Peli
Journal:  Comput Biol Med       Date:  2006-09-29       Impact factor: 4.589

5.  In-the-spectacle-lens telescopic device.

Authors:  Eli Peli; Fernando Vargas-Martín
Journal:  J Biomed Opt       Date:  2008 May-Jun       Impact factor: 3.170

Review 6.  Applications of augmented reality in ophthalmology [Invited].

Authors:  Güneş Aydındoğan; Koray Kavaklı; Afsun Şahin; Pablo Artal; Hakan Ürey
Journal:  Biomed Opt Express       Date:  2020-12-21       Impact factor: 3.732

7.  Extended wearing trial of Trifield lens device for 'tunnel vision'.

Authors:  Russell L Woods; Robert G Giorgi; Eliot L Berson; Eli Peli
Journal:  Ophthalmic Physiol Opt       Date:  2010-05       Impact factor: 3.117

8.  Inattentional blindness with the same scene at different scales.

Authors:  Henry L Apfelbaum; Christina Gambacorta; Russell L Woods; Eli Peli
Journal:  Ophthalmic Physiol Opt       Date:  2010-03       Impact factor: 3.117

9.  Treatment of homonymous visual field defects.

Authors:  Daniel R Gold; Lori L Grover
Journal:  Curr Treat Options Neurol       Date:  2012-02       Impact factor: 3.598

10.  Homonymous Hemianopia: A Critical Analysis of Optical Devices, Compensatory Training, and NovaVision.

Authors:  Victoria S Pelak; Mark Dubin; Edward Whitney
Journal:  Curr Treat Options Neurol       Date:  2007-01       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.